ID   GM1500-6TG-A12
AC   CVCL_H616
SY   GM1500 6TG-A12; GM 1500 6TG-A12; GM 1500 6TG-A1 2; GM 1500 6 TG-A12; GM1500TG-A12
DR   Wikidata; Q54847546
RX   Patent=US4608337;
RX   PubMed=6969366;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Problematic cell line: Misclassified. Parent cell line (GM01500) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8038.
CC   Characteristics: Secretes IgG2 kappa.
CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Misspelling: GM1500-GTG-A12; Note=Occasionally.
CC   Misspelling: GTG-A12(GM1500); Note=Occasionally.
CC   Derived from sampling site: Peripheral blood.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D870 ! GM01500
SX   Male
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 14
RX   Patent=US4608337;
RA   Croce C.M.;
RT   "Human hybridomas and the production of human monoclonal antibodies by
RT   human hybridomas.";
RL   Patent number US4608337, 26-Aug-1986.
RX   PubMed=6969366; DOI=10.1038/288488a0;
RA   Croce C.M., Linnenbach A., Hall W., Steplewski Z., Koprowski H.;
RT   "Production of human hybridomas secreting antibodies to measles
RT   virus.";
RL   Nature 288:488-489(1980).